FBW7 Regulates the Autophagy Signal in Mesangial Cells Induced by High Glucose

Biomed Res Int. 2019 Apr 21:2019:6061594. doi: 10.1155/2019/6061594. eCollection 2019.

Abstract

Aims: Abnormal regulation of autophagy participates in the development of diabetic nephropathy. mTOR is the most common negative regulator of the autophagy signaling pathway. FBW7 constitutes the SCF (Skp1-Cullin1-F-box protein) recognition subunit of E3 ubiquitin ligase, and mTOR is a substrate of FBW7 that can be modified by ubiquitination and be degraded via proteasomes. In this study, we explored the relationship between FBW7 and autophagy and examined the effects of FBW7 on the occurrence of diabetic nephropathy in vitro.

Materials and methods: We cultured mesangial cells induced by high glucose in vitro and used rapamycin as a specific mTOR inhibitor, performed FBW7 gene overexpression, and detected the expression of autophagy signal and inflammatory factors by WB, ELISA, RT-PCR, and immunofluorescence.

Results: High glucose can downregulate the expression of FBW7 and activate mTOR signal, which leads to diminished autophagy in renal mesangial cells, as well as renal inflammatory cytokines and fibrotic factors. RAPA, as a specifically inhibitor of mTOR, can decrease inflammatory cytokines and fibrotic factors by inhibiting mTOR. Moreover, FBW7 gene overexpression can increase autophagy by inhibiting mTOR signal; at the same time, the inflammatory cytokines and fibrotic factors were decreased in mesangial cells.

Conclusions: FBW7 was decreased in renal mesangial cells induced by high glucose, and FBW7 gene overexpression can increase autophagy by inhibiting mTOR signaling and ameliorate inflammation and fibrosis.

MeSH terms

  • Autophagy / drug effects
  • Autophagy / genetics*
  • Cell Line
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / genetics
  • Diabetic Nephropathies / pathology
  • F-Box-WD Repeat-Containing Protein 7 / genetics*
  • Gene Expression Regulation / drug effects
  • Glucose / metabolism
  • Glucose / toxicity
  • Humans
  • Mesangial Cells / drug effects
  • Phosphorylation / drug effects
  • Proteasome Endopeptidase Complex / drug effects
  • Proteasome Endopeptidase Complex / genetics
  • Proteolysis / drug effects
  • Signal Transduction / drug effects
  • Sirolimus / pharmacology
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • TOR Serine-Threonine Kinases / genetics*
  • Ubiquitination / drug effects

Substances

  • F-Box-WD Repeat-Containing Protein 7
  • FBXW7 protein, human
  • TOR Serine-Threonine Kinases
  • Proteasome Endopeptidase Complex
  • Glucose
  • Sirolimus